XT
DERM icon

XTX Topco’s Journey Medical DERM Stock Holding History

XTX Topco’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
29,364
+12,968
+79% +$101K ﹤0.01% 2994
2025
Q4 		$126K Buy
+16,396
New +$129K ﹤0.01% 2569
2024
Q2 		– Sell
-36,548
Closed -$134K – 1991
2024
Q1 		$134K Buy
36,548
+13,811
+61% +$60.1K 0.02% 1286
2023
Q4 		$131K Buy
+22,737
New +$101K 0.03% 1070

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

XTX Topco's DERM Position: Q1 2026 in Review

XTX Topco increased its Journey Medical (DERM) stake by 79% in Q1 2026, buying an estimated $101K and bringing the position to 29,364 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

XTX Topco first reported a position in DERM in Q4 2023 and has held it in 4 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • XTX Topco held 29,364 shares of Journey Medical worth $138K as of Q1 2026.
  • XTX Topco bought 12,968 Journey Medical shares in Q1 2026, an estimated $101K.
  • Journey Medical made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2994 holding.
  • XTX Topco first reported a position in Journey Medical in Q4 2023 and has held it in 4 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.